Clinical Trials Directory

Trials / Conditions / Stage IIA Fallopian Tube Cancer

Stage IIA Fallopian Tube Cancer

9 registered clinical trials studyying Stage IIA Fallopian Tube Cancer.

StatusTrialSponsorPhase
WithdrawnSirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Perito
NCT02833506
Roswell Park Cancer InstitutePhase 1
WithdrawnVaccine Therapy and IDO1 Inhibitor INCB024360 in Treating Patients With Epithelial Ovarian, Fallopian Tube, or
NCT01982487
Roswell Park Cancer InstitutePhase 1 / Phase 2
CompletedSirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian Epithelial, Fallopian Tube, or Pri
NCT01536054
Roswell Park Cancer InstitutePhase 1
CompletedVaccine Therapy and Cyclophosphamide in Treating Patients With Stage II-III Breast or Stage II-IV Ovarian, Pri
NCT01606241
Mayo ClinicPhase 1
TerminatedGranisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherap
NCT01275664
Gynecologic Oncology GroupN/A
CompletedPsychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer
NCT01764802
Ohio State University Comprehensive Cancer CenterPhase 2
CompletedOPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Ca
NCT00857545
Gynecologic Oncology GroupPhase 2
CompletedChanges in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritone
NCT01080521
Gynecologic Oncology Group—
CompletedCollecting Tumor Samples From Patients With Gynecological Tumors
NCT00897442
Gynecologic Oncology Group—